| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-09 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-08 |
| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
| mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-07 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |